Advanced Bladder Cancer Treatment in Florida: Proton Therapy, EBRT, SBRT & Personalized Care
What Is Bladder Cancer?
Bladder cancer is one of the most common cancers in the United States, with an estimated 84,870 new cases expected in 2025 according to the American Cancer Society. It is the sixth most common cancer overall and primarily affects adults over age 55 — roughly 90% of diagnoses occur in people 55 and older, with a median age at diagnosis of 73.
At Ackerman Cancer Center in Northeast Florida, our board-certified radiation oncologists provide advanced, evidence-based bladder cancer treatment using the latest radiation therapy techniques, including external beam radiation therapy (EBRT), stereotactic body radiation therapy (SBRT), and proton therapy. Our approach is designed to maximize cancer control while preserving bladder function and quality of life — giving you options beyond traditional surgery.
Types of Bladder Cancer
The type of bladder cancer you have influences which treatments are most effective:
- Urothelial carcinoma (transitional cell carcinoma): The most common form, accounting for over 90% of all bladder cancers in the United States. It begins in the urothelial cells that line the inside of the bladder.
- Squamous cell carcinoma: Makes up 3–5% of bladder cancers. Often associated with chronic bladder irritation, long-term urinary tract infections, or catheter use.
- Adenocarcinoma: A rare form representing only 1–2% of cases. Develops from gland-forming cells in the bladder lining.
- Small cell carcinoma: Less than 1% of bladder cancers. An aggressive subtype that originates in neuroendocrine cells and typically requires a combination of systemic and local treatments.
Risk Factors
Understanding your risk factors can help with early detection and prevention:
- Smoking: The single greatest risk factor for bladder cancer, responsible for approximately half of all cases. Smokers are three to seven times more likely to develop bladder cancer than non-smokers.
- Gender: Men are approximately four times more likely to develop bladder cancer than women. An estimated 65,000 of the 84,870 projected 2025 cases will be in men.
- Chemical and occupational exposure: Workers in industries involving rubber, leather, textiles, paint, and printing face elevated risk due to exposure to aromatic amines.
- Age: Risk increases significantly after age 55, with the highest incidence in adults aged 65–74.
- Chronic bladder irritation: Long-term UTIs, kidney stones, bladder stones, and prolonged catheter use can increase risk — particularly for squamous cell carcinoma.
- Prior radiation or chemotherapy: Previous pelvic radiation therapy or treatment with certain chemotherapy drugs (such as cyclophosphamide) can increase bladder cancer risk.
Family history: A family history of bladder cancer, as well as certain inherited genetic variants, can elevate personal risk.
What Is the Treatment for Bladder Cancer?
The right bladder cancer treatment depends on several key factors:
- Stage: Whether the cancer is confined to the bladder lining (non-muscle invasive), has grown into the bladder muscle wall (muscle-invasive), or has spread beyond the bladder (metastatic).
- Tumor grade: How abnormal the cancer cells appear under a microscope, which indicates how aggressively the cancer is likely to grow.
- Overall patient health: Age, existing medical conditions, and your ability to tolerate specific treatments all play a role in determining the best approach.
Your care team will evaluate these factors and work with you to develop a personalized treatment plan that balances cancer control with your quality of life and personal goals.
Bladder Cancer Treatment Options
1. Surgery (TURBT, Cystectomy)
Transurethral resection of bladder tumor (TURBT) is typically the first treatment for non-muscle invasive bladder cancer. A surgeon uses a cystoscope to remove visible tumor tissue from the bladder wall. For muscle-invasive disease, radical cystectomy — removal of the entire bladder along with surrounding tissues — has been the traditional standard of care. In men, this includes removal of the prostate and seminal vesicles. Partial cystectomy may be an option for select patients with a single, accessible tumor.
2. Chemotherapy
Chemotherapy uses drugs to kill cancer cells and may be administered before surgery (neoadjuvant) to shrink tumors, after surgery (adjuvant) to reduce recurrence risk, or alongside radiation therapy to enhance its effectiveness. Cisplatin-based regimens are the most commonly used for muscle-invasive bladder cancer. For non-muscle invasive disease, chemotherapy drugs like mitomycin or gemcitabine may be instilled directly into the bladder (intravesical chemotherapy).
3. Immunotherapy
Immunotherapy helps your immune system recognize and attack cancer cells. BCG (Bacillus Calmette-Guérin) is the most widely used intravesical immunotherapy for early-stage bladder cancer and has been shown to reduce recurrence risk by approximately 32% compared to chemotherapy alone. For advanced or BCG-unresponsive bladder cancer, immune checkpoint inhibitors like pembrolizumab may be recommended.
4. Radiation Therapy (EBRT and SBRT)
Radiation therapy uses precisely targeted energy beams to destroy cancer cells while sparing surrounding healthy tissue. At Ackerman Cancer Center, radiation therapy is a central part of our bladder preservation approach — allowing many patients to avoid bladder removal while still achieving strong cancer control. Our radiation oncologists use EBRT, SBRT, and proton therapy techniques tailored to each patient’s cancer and anatomy.
5. Proton Therapy
Proton therapy delivers high doses of radiation directly to a tumor, sparing nearby healthy tissue. This pinpoint accuracy has been shown across multiple disease sites to improve overall survival – either by reducing life-threatening toxicities, being more biologically potent at tumor killing, or allowing for more targeted and escalated doses of radiation.
Unlike conventional X-ray radiation, proton therapy is more targeted – better sparing patients from debilitating and costly side effects.
What Is the Most Common Treatment for Bladder Cancer?
Surgery — specifically TURBT for early-stage disease and radical cystectomy for muscle-invasive disease — has long been considered the standard baseline treatment for bladder cancer. However, surgery is not the only effective option, and it is not right for everyone.
Not all patients are candidates for radical cystectomy. Advanced age, cardiovascular disease, diabetes, and other medical conditions can make major surgery too risky. Even for patients who could tolerate surgery, many prefer to explore alternatives that preserve their natural bladder.
This is where bladder preservation through trimodal therapy (TMT) has become an increasingly important approach. TMT combines three treatments:
- Maximal TURBT to remove as much visible tumor as possible
- Concurrent chemotherapy to enhance the effectiveness of radiation
- Radiation therapy (EBRT) to eliminate remaining cancer cells
Modern TMT achieves complete response rates of up to 88%, and propensity-matched studies show no significant difference in overall survival or disease-free survival compared to radical cystectomy. After five years, 60–85% of TMT patients still have a functioning, cancer-free bladder — and research shows TMT provides an additional 1.6 quality-adjusted life years compared to immediate surgery.
Benefits of Radiation Therapy for Bladder Cancer
- Organ preservation: Proton therapy, EBRT and SBRT are the foundation of bladder preservation approaches, allowing many patients to keep their natural bladder and avoid the lifestyle changes that come with bladder removal and urinary diversion.
- Non-invasive: Radiation therapy requires no incisions, no anesthesia, and no hospital stay. Treatments are delivered on an outpatient basis.
- Outpatient treatment: Most patients drive themselves to and from daily treatments and continue normal activities throughout their course of care.
- Precision targeting minimizes collateral damage: Advanced techniques like IMRT, VMAT, and proton therapy conform the radiation dose tightly to the tumor, reducing exposure to the rectum, bowel, and other surrounding organs.
- Strong cancer control: When combined with chemotherapy as part of trimodal therapy, radiation-based bladder preservation achieves five-year overall survival rates comparable to radical cystectomy.
Bladder Cancer Treatment for Men
Bladder cancer disproportionately affects men. With a male-to-female incidence ratio of approximately 4:1, an estimated 65,000 men will be diagnosed with bladder cancer in 2025 alone. A man’s lifetime risk of developing bladder cancer is approximately 1 in 125 — making this a diagnosis that should be on every man’s radar, particularly those over 55 with a history of smoking or occupational chemical exposure.
For men facing a bladder cancer diagnosis, treatment decisions carry significant quality-of-life implications:
Age and comorbidities matter >
Quality of life after treatment >
Equivalent outcomes, different experience >
If you are a man diagnosed with bladder cancer, we encourage you to discuss all available treatment options with your care team — including radiation-based bladder preservation — before making a decision.
Who Is a Candidate for Radiation Treatment?
You may be a candidate for radiation-based bladder cancer treatment if you:
- Prefer to avoid surgery or want to explore bladder preservation options before committing to radical cystectomy
- Are not a surgical candidate due to age, cardiovascular risk, or other medical conditions that make major surgery inadvisable
- Have localized muscle-invasive disease (T2–T3a) — particularly if your TURBT achieved maximal tumor debulking with no residual gross disease
- Have adequate bladder function with no significant pre-existing urinary issues that would limit the benefit of preserving the bladder
- Have no hydronephrosis (blockage of urine flow from the kidney), which can indicate locally advanced disease less suitable for radiation-based preservation
During your consultation at Ackerman Cancer Center, our radiation oncologists will evaluate your cancer stage, imaging, surgical history, and overall health to determine whether EBRT, SBRT, proton therapy, or a combination approach is the best path forward for you.
The Ackerman Advantage
Ackerman Cancer Center is the world’s first private physician-owned proton therapy practice, founded in 1997 by Dr. Scot Ackerman. For nearly three decades, our team has delivered advanced radiation therapy to thousands of patients across Northeast Florida, including over 3,500 proton therapy patients. Our radiation oncologists are board-certified specialists who design every treatment plan with precision, compassion, and a commitment to the best possible outcome.
- Locations across Florida:
- Mandarin (Jacksonville, FL)
- Riverside (Jacksonville, FL)
- Amelia Island, FL
- St. Augustine, FL (World Golf Village Area)
- Advanced radiation technology: Proton therapy IMRT, VMAT, SBRT, image-guided radiation therapy (IGRT), and more
- Multidisciplinary cancer team: Board-certified radiation oncologists, oncology -specialized nurse practitioners, certified medical physicists, dosimetrists, radiation therapists, and oncology nurses working together on every case and have direct access to a board-certified team of Urologists at Ackerman Urology.
- Personalized treatment plans: Every patient receives a treatment plan designed specifically for their cancer, anatomy, and goals — not a one-size-fits-all protocol
What to Expect During Radiation Therapy
Being diagnosed with cancer raises many questions. Learn what to expect during cancer treatment here.
For more information about the Ackerman Cancer Center and its available treatment options, please call (904) 880-5522 or click below.
- Consultation: You will meet with a board-certified radiation oncologist who will review your pathology, imaging, and medical history. Together, you will discuss treatment options, expected outcomes, and what daily treatment will look like.
- Imaging and planning: Advanced imaging, available on-site, and often same-day (CT simulation, and in some cases MRI) is used to create a detailed map of your anatomy. Our dosimetry and physics teams then design a customized treatment plan that targets the cancer while minimizing dose to the bladder wall, rectum, and bowel.
- Treatment sessions: For EBRT and SBRT, you will receive daily treatments Monday through Friday for approximately four to seven weeks. Each session takes less than 20 minutes. For Proton Therapy, you will receive daily treatment Monday-Friday, with optional Saturday’s to lessen overall treatment times, in approximately four to seven weeks. Treatments are painless — most patients describe the experience as similar to getting an X-ray.
Comparing Bladder Cancer Treatments
Treatment
Invasiveness
Bladder Preservation
Recovery
Effectiveness
Surgery (Radical Cystectomy)
High — major operation requiring hospital stay
No — bladder is removed
Long — weeks to months; requires urinary diversion adaptation
High — 5-year OS ~66%
Chemotherapy
Medium — systemic; IV or intravesical
Yes
Moderate — fatigue, nausea, immune suppression
Moderate — most effective combined with other treatments
Immunotherapy (BCG/Checkpoint Inhibitors)
Medium — intravesical or IV
Yes
Moderate — immune-related side effects possible
Varies — strong for early-stage; advancing for advanced disease
EBRT (with concurrent chemo)
Low — non-invasive, outpatient
Yes — 60–85% bladder preservation at 5 years
Minimal — most patients maintain normal activities
High — 5-year OS comparable to surgery; up to 88% complete response
SBRT
Low — non-invasive, outpatient, 5 or fewer sessions
Yes (emerging evidence)
Minimal — completed in approximately one week
High (clinical trials ongoing; early results promising)
Frequently Asked Questions About Bladder Cancer Treatment
What is the best treatment for bladder cancer?
There is no single “best” treatment for all bladder cancer patients. The optimal approach depends on the cancer’s stage and grade, your overall health, and your personal treatment goals. The radiation oncologist at Ackerman Cancer Center can help you weigh the benefits and tradeoffs of each approach.
What is the most common treatment for bladder cancer?
Surgery is the most frequently used treatment overall. TURBT is the standard initial treatment for early-stage (non-muscle invasive) bladder cancer, and radical cystectomy has traditionally been the standard for muscle-invasive disease. However, radiation-based bladder preservation using trimodal therapy has become an increasingly accepted alternative for muscle-invasive bladder cancer, with growing clinical evidence supporting equivalent survival outcomes.
What are the treatment options for bladder cancer?
Bladder cancer treatment options include transurethral resection (TURBT), intravesical therapy (BCG or chemotherapy instilled into the bladder), systemic chemotherapy, immunotherapy (checkpoint inhibitors), radical or partial cystectomy, and radiation therapy — including using IMRT, VMAT, or proton therapy, and SBRT. Many patients receive a combination of these treatments. At Ackerman Cancer Center, we offer the full range of advanced radiation therapies, including proton therapy.
Can radiation therapy cure bladder cancer?
Yes. When used as part of a trimodal therapy approach — combining maximal TURBT, concurrent chemotherapy, and radiation therapy — radiation-based treatment achieves complete response rates of up to 88% and five-year survival rates comparable to radical cystectomy. For patients with localized muscle-invasive bladder cancer, this is considered a curative-intent treatment. Radiation therapy can also be used in a palliative role for advanced disease to relieve symptoms such as bleeding or pain.
What is EBRT for bladder cancer?
EBRT (external beam radiation therapy) delivers precisely targeted radiation to the bladder tumor from outside the body using a machine called a linear accelerator. At Ackerman Cancer Center, we use advanced EBRT techniques including IMRT and VMAT, which shape the radiation beams to conform to the tumor while minimizing dose to surrounding organs like the rectum and bowel. Treatment is painless, takes less than 20 minutes per session, and is delivered on an outpatient basis — typically five days a week for four to seven weeks.
What is SBRT, and how is it different?
SBRT (stereotactic body radiation therapy) delivers very high doses of radiation in five or fewer treatment sessions, compared to the 20–32 sessions required with standard EBRT. SBRT uses advanced imaging and precision targeting to focus radiation on a small, well-defined area. For bladder cancer, SBRT is an emerging approach being studied in clinical trials (including the ARCHER trial) as a shorter-course alternative to conventional radiation. The potential advantages include completing treatment in approximately one week instead of four to seven weeks, with promising early results for cancer control and tolerability.
What are the treatments for bladder cancer in men?
Men have the same treatment options as women — surgery, chemotherapy, immunotherapy, and radiation therapy — but there are important differences in how those treatments affect male patients. Radical cystectomy in men involves removal of the bladder, prostate, and seminal vesicles, which significantly impacts sexual function and urinary continence. Bladder preservation through trimodal therapy allows men to keep their natural bladder and avoid these consequences while achieving comparable cancer control. Given that men are four times more likely to develop bladder cancer, understanding these differences is especially important.
Is radiation therapy better than surgery?
Radiation therapy and surgery are different approaches to the same goal. Propensity-matched studies show no statistically significant difference in overall survival or disease-free survival between trimodal therapy (radiation-based preservation) and radical cystectomy. The key difference is quality of life: trimodal therapy preserves the natural bladder and avoids the lifestyle changes associated with urinary diversion. The right choice depends on your specific cancer, health status, and personal priorities. We recommend discussing both options thoroughly with your care team.
How long does bladder cancer treatment take?
Treatment duration varies by approach. Standard EBRT is delivered daily (Monday through Friday) for approximately four to seven weeks. SBRT may be completed in as few as five sessions over one to two weeks. Each individual radiation treatment session takes less than 20 minutes. Chemotherapy cycles, if included, are coordinated with the radiation schedule. Surgery and recovery from radical cystectomy typically require several weeks to months. Your care team will provide a detailed timeline based on your specific treatment plan.
Where can I get bladder cancer treatment in Florida?
Ackerman Cancer Center provides advanced bladder cancer treatment at two locations across Northeast Florida: Mandarin (Jacksonville) and Amelia Island. As the world’s first private proton therapy practice, we offer treatment technologies — including proton therapy, IMRT, VMAT, and SBRT — that are not available at most radiation centers. Call (904) 880-5522 to schedule a consultation with one of our board-certified radiation oncologists.
Get Advanced Bladder Cancer Treatment
A bladder cancer diagnosis is overwhelming — but you have more options than you may realize. At Ackerman Cancer Center, our radiation oncologists specialize in advanced, precise treatment techniques designed to control your cancer while preserving your quality of life.
Take the next step:
- Schedule a consultation to discuss your diagnosis and treatment options with a board-certified radiation oncologist
- Speak with our team about whether EBRT, SBRT, or proton therapy may be right for your specific case
- Verify your insurance — our staff will help you understand your coverage and out-of-pocket costs before treatment begins (we Accept 99% of all insurance plans)
